Suppression of nitric oxide synthase by thienodolin in lipopolysaccharide- stimulated RAW 264.7 murine macrophage cells

Natural Product Communications

Volumn 7, Issue 6, 2012, Pages 789-794

  Park, Eun Jung ^a   Pezzuto, John M ^a   Jang, Kyoung Hwa ^b   Nam, Sang Jip ^b   Bucarey, Sergio A ^b   Fenical, William ^b  

^a UNIVERSITY OF HAWAII AT HILO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cancer prevention; Inducible nitric oxide synthase; Inflammation; Macrophage; Nitric oxide; Thienodolin

Indexed keywords

DECHLOROTHIENODOLIN; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL PRODUCT; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; STAT1 PROTEIN; THIENODOLIN; TRANSCRIPTION FACTOR RELA; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CHILE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME INHIBITION; GENE EXPRESSION; IC 50; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SEDIMENT; SIGNAL TRANSDUCTION; STREPTOMYCES;

MURINAE; STREPTOMYCES SP.;

EID: 84864646483     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1200700625     Document Type: Article

References (40)

1. Mayer B, Hemmens B. (1997) Biosynthesis and action of nitric oxide in mammalian cells. Trends in Biochemical Sciences, 22, 477-481. (Pubitemid 27515914)
2. Bates TE, Loesch A, Burnstock G, Clark JB. (1995) Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochemical and Biophysical Research Communications, 213, 896-900.
3. Liu VW, Huang PL. (2008) Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovascular Research, 77, 19-29. (Pubitemid 351195168)
4. Aktan F. (2004) iNOS-mediated nitric oxide production and its regulation. Life Sciences, 75, 639-653.
5. Bricker S. (2004) The Anaesthesia Science Viva Book. Cambridge University Press, Cambridge, 135
6. Hiraku Y, Kawanishi S, Ichinose T, Murata M. (2010) The role of iNOS-mediated DNA damage in infection- and asbestos-induced carcinogenesis. Annals of the New York Academy of Sciences, 1203, 15-22.
7. Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA.(2002) Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Current Pharmaceutical Design, 3, 177-200. (Pubitemid 34449889)
8. Pilon G, Charbonneau A, White PJ, Dallaire P, Perreault M, Kapur S, Marette A. (2010) Endotoxin mediated-iNOS induction causes insulin resistance via ONOO-induced tyrosine nitration of IRS-1 in skeletal muscle. PLoS One, 5, e15912.
9. Suschek CV, Schnorr O, Kolb-Bachofen V. (2004) The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? Current Molecular Medicine, 4, 763-775. (Pubitemid 39369294)
10. Coussens LM, Werb Z. (2002) Inflammation and cancer. Nature, 420, 860-867. (Pubitemid 36019639)
11. Chang AH, Parsonnet J. (2010) Role of bacteria in oncogenesis. Clinical Microbiology Reviews, 23, 837-857.
12. Singh S, Gupta AK. (2011) Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemotherapy and Pharmacology, 67, 1211-1224.
13. Kanbe K, Naganawa H, Nakamura KT, Okami Y, Takeuchi T. (1993) Thienodolin, a new plant growth-regulating substance produced by a Streptomycete strain: II. Structure of thienodolin. Bioscience Biotechnology and Biochemistry, 57, 636-637.
14. Engqvist R, Javaid A, Bergman J. (2004) Synthesis of thienodolin. European Journal of Organic Chemistry, 2589-2592.
15. Nicolin V, Ponti C, Narducci P, Grill V, Bortul R, Zweyer M, Vaccarezza M, Zauli G. (2005) Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, 286, 945-954. (Pubitemid 41434218)
16. Lu YC, Yeh WC, Ohashi PS. (2008) LPS/TLR4 signal transduction pathway. Cytokine, 42, 145-151.
17. Kleinert H, Pautz A, Linker K, Schwarz PM. (2004) Regulation of the expression of inducible nitric oxide synthase. European Journal of Pharmacology, 500, 255-266. (Pubitemid 39304013)
18. Luqman S, Pezzuto JM. (2010) NFkappaB:a promising target for natural products in cancer chemoprevention. Phytotherapy Research, 24, 949-963.
19. Majdalawieh A, Ro HS. (2010) Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages. Mediators of Inflammation, 2010, article ID: 823821, 1-27 pages.
20. Henkel T, Machleidt T, Alkalay I, Krönke M, Ben-Neriah Y, Baeuerle PA. (1993) Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature, 365, 182-185. (Pubitemid 23282067)
21. Morris KR, Lutz RD, Choi HS, Kamitani T, Chmura K, Chan ED. (2003) Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infection and Immunity, 71, 1442-1452. (Pubitemid 36254331)
22. Park EJ, Cheenpracha S, Chang LC, Kondratyuk TP, Pezzuto JM. (2011) Inhibition of lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression by 4-[(2′-O-acetyl-α-L-rhamnosyloxy) benzyl]isothiocyanate from Moringa oleifera. Nutrition and Cancer, 63, 971-982.
23. Schmitz ML, Baeuerle PA. (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO Journal, 10, 3805-3817.
24. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacology & Therapeutics, 100, 171-194. (Pubitemid 37377912)
25. Thomas KE, Galligan CL, Newman RD, Fish EN, Vogel SN. (2006) Contribution of interferon-beta to the murine macrophage response to the tolllike receptor 4 agonist, lipopolysaccharide. Journal of Biological Chemistry, 281, 31119-31130. (Pubitemid 44582166)
26. Jacobs AT, Ignarro LJ. (2001) Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. Journal of Biological Chemistry, 276, 47950-47957.
27. Tsoyi K, Nizamutdinova IT, Jang HJ, Mun L, Kim HJ, Seo HG, Lee JH, Chang KC. (2010) Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages. Shock, 34, 608-614.
28. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Ueyama T, Ishida T, Inoue N, Hirata K, Akita H, Yokoyama M. (2000) Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation, 101, 931-937. (Pubitemid 30117890)
29. Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P. (2008) The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate, 68, 223-229. (Pubitemid 351186234)
30. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. (2007) Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators of Inflammation, 2007, article ID: 45673, 1-10 pages.
31. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. Journal of Immunology, 175, 3339-3346. (Pubitemid 41170555)
32. Youn HS, Lim HJ, Choi YJ, Lee JY, Lee MY, Ryu JH. (2008) Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists. International Journal of Immunopharmacology, 8, 495-501.
33. Park EJ, Min HY, Chung HJ, Ahn YH, Pyee JH, Lee SK. (2011) Pinosylvin suppresses LPS-stimulated inducible nitric oxide synthase expression via the MyD88-independent, but TRIF-dependent downregulation of IRF-3 signaling pathway in mouse macrophage cells. Cellular Physiology and Biochemistry, 27, 353-362.
34. Wagner C, El Omari M, König GM. (2009) Biohalogenation: nature's way to synthesize halogenated metabolites. Journal of Natural Products, 72, 540-553.
35. Seibold C, Schnerr H, Rumpf J, Kunzendorf A, Hatscher C, Wage T, Ernyei AJ, Dong C, Naishmith JH, Van Pée KH.(2006) A flavin-dependent tryptophan 6-halogenase and its use in modification of pyrrolnitrin biosynthesis. Biocatalysis and Biotransformation, 24, 401-408. (Pubitemid 44921869)
36. Oh GS, Pae HO, Choi BM, Chae SC, Lee HS, Ryu DG, Chung HT. (2004) 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochemical and Biophysical Research Communications, 320, 1156-1162.
37. Park EJ, Cheenpracha S, Chang LC, Pezzuto JM. (2011) Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by epimuqubilin A via IKK/IκB/NF-κB pathways in lipopolysaccharide-stimulated RAW 264.7 cells. Phytochemistry Letters, 4, 426-431.
38. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
39. Bradford MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
40. Zhao L, Tao JY, Zhang SL, Jin F, Pang R, Dong JH. (2010) N-Butanol extract from Melilotus suaveolens Ledeb affects pro- and anti-inflammatory cytokines and mediators. Evidence-based Complementary and Alternative Medicine, 7, 97-106.